ロード中...
Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
Abstract Background Leukemia stem cells (LSCs) are responsible for the initiation and perpetuation of acute myeloid leukemia (AML), and also represent leukemia relapse reservoirs with limited therapeutic approaches. Thus, additional treatment strategies are medical unmet needs to eliminate LSCs. Met...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2022-05-01
|
| シリーズ: | Experimental Hematology & Oncology |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s40164-022-00282-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|